Ontogeny, Breadth, and Specificity of Circulating ADCC-Mediating Antibodies in HIV-1 Infected Individuals

被引：0
|
作者：
Pollara, J. [1 ]
Morris, L. [2 ]
Meguid, N. [1 ]
Pickeral, J. [1 ]
Hoxie, J. [3 ]
Kappes, J. [4 ]
Ochsenbauer, C. [4 ]
Soderberg, K. [1 ]
Tomaras, G. [1 ]
Haynes, B. [1 ]
Montefiori, D. [1 ]
Ferrari, G.
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Natl Inst Communicable Dis, Johannesburg, South Africa
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Univ Alabama, Birmingham, AL USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A66 / A67
页数：2
相关论文
共 50 条
  • [21] The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART
    Peng, Jinsong
    Vigorito, Michael
    Liu, Xiangqian
    Zhou, Dunjing
    Wu, Xiongwen
    Chang, Sulie L.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 218 (1-2) : 94 - 101
  • [22] Virolysis of complement-resistant HIV-1 by antibodies in the plasmas from HIV-1-infected individuals
    Yu, Qigui
    Shikuma, Cecilia
    Shiramizu, Bruce
    Hu, Ningjie
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [23] LACK OF AUTOLOGOUS NEUTRALIZING ANTIBODIES IN THE CEREBROSPINAL-FLUID OF HIV-1 INFECTED INDIVIDUALS
    VONGEGERFELT, A
    CHIODI, F
    KEYS, B
    NORKRANS, G
    HAGBERG, L
    FENYO, EM
    BROLIDEN, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) : 1133 - 1138
  • [24] A MONOCLONAL-ANTIBODY TO HIV-1 MEDIATING CELLULAR CYTOTOXICITY (ADCC) AND NEUTRALIZATION
    BROLIDEN, PA
    LJUNGGREN, K
    HINKULA, J
    NORRBY, E
    AKERBLOM, L
    WAHREN, B
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 29 - 29
  • [25] FINE SPECIFICITY OF THE HUMORAL IMMUNE-RESPONSE TO HIV-1 GP-160 IN HIV-1 INFECTED INDIVIDUALS FROM TANZANIA
    NKYA, WMMM
    WARREN, RQ
    WOLF, H
    HENDRIX, CW
    TESHA, J
    REDFIELD, RR
    MELCHER, GP
    BURKE, DS
    KANDA, P
    KENNEDY, RC
    JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (01) : 61 - 66
  • [26] Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression
    Grobben, Marloes
    Bakker, Margreet
    Schriek, Angela I.
    Levels, Liesbeth J. J.
    Umotoy, Jeffrey C.
    Tejjani, Khadija
    van Breemen, Marielle J.
    Lin, Ryan N.
    de Taeye, Steven W.
    Ozorowski, Gabriel
    Kootstra, Neeltje A.
    Ward, Andrew B.
    Kent, Stephen J.
    Hogarth, P. Mark
    Wines, Bruce D.
    Sanders, Rogier W.
    Chung, Amy W.
    van Gils, Marit J.
    PLOS PATHOGENS, 2024, 20 (12)
  • [27] HIV-1 infected individuals have antibody dependent lymphokine activated killer cell cytotoxicity (LAK-ADCC) against HIV-1 core antigens.
    Sum, BM
    Kim, YB
    Baum, LL
    FASEB JOURNAL, 1999, 13 (05): : A964 - A964
  • [28] Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals
    Esbjornsson, Joakim
    Mansson, Fredrik
    Kvist, Anders
    Isberg, Per-Erik
    Biague, Antonio J.
    da Silva, Zacarias J.
    Jansson, Marianne
    Fenyo, Eva Maria
    Norrgren, Hans
    Medstrand, Patrik
    AIDS, 2014, 28 (07) : 949 - 957
  • [29] Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients
    Söderlund, J
    Hirbod, T
    Goh, LE
    Andersson, J
    Broliden, K
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (09) : 663 - 669
  • [30] CROSS-NEUTRALIZING ANTIBODIES TO HIV-1(ANT70) AND HIV-1(IIIB) IN SERA OF AFRICAN AND BELGIAN HIV-1-INFECTED INDIVIDUALS
    NKENGASONG, JN
    PEETERS, M
    NDUMBE, P
    JANSSENS, W
    WILLEMS, B
    FRANSEN, K
    NGOLLE, M
    PIOT, P
    VANDERGROEN, G
    AIDS, 1994, 8 (08) : 1089 - 1096
12345